Abstract
For many years there has been an intensive search for antivirals that are active against rhinoviruses. The reason is very simple: rhinoviruses are the main culprits of the common cold, and although admittedly the common cold is a very mild affliction, almost all of us from time to time use medicine to relieve our cold symptoms. Given the fact that a specific antiviral agent is not included in any of the drugs currently marketed for the treatment of colds, the potential market for an effective common cold drug is huge.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Nakib W, Tyrrell DAJ (1987): A “new” generation of more potent synthetic antirhinovirus compounds: Comparison of their MICs and their synergistic interactions. Antiviral Res 8:179–882.
Al-Nakib W, Higgins PG, Barrow GI, Tyrrell DAJ, Andries K, Vanden Bussche G, Taylor N, Janssen PAJ (1989): Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother 33:522–525.
Andries K, Dewindt B, De Brabander M, Stokbroekx R, Janssen P (1988): In vitro activity of R 61837, a new antirhinovirus compound. Arch Virol 101:155–67.
Andries K, Dewindt B, Snoeks J, Willebrords R (1989): Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization. Arch Virol 106:51–61.
Andries K, Dewindt B, Snoeks J, Wouters L, Moereels H, Lewi PJ, Janssen PAJ (1990): Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol 64:1117–1123.
Andries K, Dewindt B, Snoeks J, Willebrords R, Stokbroekx R, Lewi, PJ (1991): A comparative test of 15 compounds against all rhinoviruses as a basis for a more rational screening. Antiviral Res 16:213–225.
Andries K, Dewindt B, Snoeks J, Willebrords R, Van Eemeren K, Stokbroekx R, Janssen PAJ (1992): In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Antimicrob Agents Chemother 36:100–107.
Anonymous (1984): Enviroxime. Drugs Future 9:221-222.
Barrow GI, Higgins PG, Tyrrell DAJ, Andries K (1990): An appraisal of the efficacy of the antiviral R 61837 in rhinovirus infections in human volunteers. Antiviral Chem Chemother 1:279–285.
Bauer DJ, Selway JWT, Batchelor JF, Tisdale M, Caldwell IC, Young DAB (1981): 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature (London) 292:369–370.
Hayden FG, Andries K, Janssen PAJ (1992). Safety and efficacy of intranasal pirodavir (R 77975) in experimental rhinovirus infection. Antimicrob Agents Chemother 36:727–732.
Ishitsuka H, Ninomiya YN, Ohsawa C, Fujiu M, Suhura Y (1982): Direct and specific inactivation of rhinovirus by chalcone Ro 09-410. Antimicrob Agents Chemother 22:617–621.
Otto MJ, Fox MP, Fancher MJ, Kuhrt MF, Diana GD, McKinlay MA (1985): In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother 27:883–886.
Rombaut B, Andries K, Boeyé A (1991): A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids. J Gen Virol 72:2153–2157.
Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht H, Johnson JE, Kamer G, Luo M, Mosser AGT, Rueckert RR, Sherry B, Vriend G (1985): Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (London) 317:145–153.
Rueckert RR (1990): Picornaviridae and their replication. In Virology, Fields BN, Knipe DM, eds. New York: Raven Press.
Smith TJ, Kremer MJ, Lou M, Vriend G, Arnold E, Kamer G, Rossmann MG, McKinlay MA, Diana GD, Otto MJ (1986): The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286–1293.
Uncapher CR, DeWitt CM, Colonno RJ (1991): The major and minor receptor group families contain all but one human rhinovirus serotype. Virology 180:814–817.
Woods MG, Diana GD, Rogge MC, Otto MJ, Dutko FJ, McKinlay MA (1989): In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother 33:2069–2074.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Andries, K. (1993). Discovery of Pirodavir, a Broad-Spectrum Inhibitor of Rhinoviruses. In: Adams, J., Merluzzi, V.J. (eds) The Search for Antiviral Drugs. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4899-6718-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-6718-3_8
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4899-6720-6
Online ISBN: 978-1-4899-6718-3
eBook Packages: Springer Book Archive